Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in miceEmma C. Fink, Benjamin L. Ebert, Marie McConkey et al.|Blood|2018Cited by 126
Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor ImmunityAndrew A. Guirguis, Mark A. Dawson, Byron Andrews et al.|Cancer Discovery|2023Cited by 114
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell DeathSylvain Garciaz, Mark A. Dawson, Andrew A. Guirguis et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2023Cited by 34
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesisAndrew A. Guirguis, Mark A. Dawson, Brian Liddicoat|Experimental Hematology|2020Cited by 6
Data from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor ImmunityAndrew A. Guirguis, Mark A. Dawson, Yaara Ofir-Rosenfeld et al.|Unknown|2023Cited by 2